Paulson & Co’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-2,175,000
| Closed | -$36.2M | – | 103 |
|
|
2016
Q3 | $36.2M | Sell |
2,175,000
-1,689,717
| -44% | -$28.1M | 0.39% | 37 |
|
|
2016
Q2 | $43.2M | Sell |
3,864,717
-62,283
| -2% | -$697K | 0.44% | 34 |
|
|
2016
Q1 | $32.8M | Sell |
3,927,000
-19,500
| -0.5% | -$163K | 0.24% | 44 |
|
|
2015
Q4 | $36.7M | Hold |
3,946,500
| – | – | 0.22% | 40 |
|
|
2015
Q3 | $44.5M | Hold |
3,946,500
| – | – | 0.23% | 47 |
|
|
2015
Q2 | $50.1M | Sell |
3,946,500
-3,500
| -0.1% | -$44.4K | 0.23% | 43 |
|
|
2015
Q1 | $36.7M | Buy |
3,950,000
+325,000
| +9% | +$3.02M | 0.19% | 47 |
|
|
2014
Q4 | $51.9M | Buy |
3,625,000
+375,000
| +12% | +$5.37M | 0.27% | 45 |
|
|
2014
Q3 | $33.7M | Buy |
3,250,000
+50,000
| +2% | +$519K | 0.14% | 59 |
|
|
2014
Q2 | $51.8M | Buy |
3,200,000
+1,807,500
| +130% | +$29.2M | 0.22% | 60 |
|
|
2014
Q1 | $22.6M | Buy |
+1,392,500
| New | +$22.6M | 0.11% | 69 |
|